These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1936116)

  • 1. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels.
    Rihet P; Demeure CE; Bourgois A; Prata A; Dessein AJ
    Eur J Immunol; 1991 Nov; 21(11):2679-86. PubMed ID: 1936116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen.
    Dessein AJ; Begley M; Demeure C; Caillol D; Fueri J; dos Reis MG; Andrade ZA; Prata A; Bina JC
    J Immunol; 1988 Apr; 140(8):2727-36. PubMed ID: 3128605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
    Dunne DW; Butterworth AE; Fulford AJ; Kariuki HC; Langley JG; Ouma JH; Capron A; Pierce RJ; Sturrock RF
    Eur J Immunol; 1992 Jun; 22(6):1483-94. PubMed ID: 1601036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human IgE responses to Schistosoma mansoni and resistance to reinfection.
    Dunne DW; Butterworth AE; Fulford AJ; Ouma JH; Sturrock RF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():99-103. PubMed ID: 1343933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of anti-antiidiotypic IgE antibodies obtained from an IgE monoclonal antibody specific for a 26-kilodalton Schistosoma mansoni antigen.
    Velge-Roussel F; Verwaerde C; Grzych JM; Auriault A; Capron A
    J Immunol; 1989 Apr; 142(7):2527-32. PubMed ID: 2494262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni.
    King CL; Xianli J; Malhotra I; Liu S; Mahmoud AA; Oettgen HC
    J Immunol; 1997 Jan; 158(1):294-300. PubMed ID: 8977202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis.
    Velge-Roussel F; Auriault C; Damonneville M; Capron A
    J Immunol; 1991 Dec; 147(11):3967-72. PubMed ID: 1719096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human antibody responses to Schistosoma mansoni: the influence of epitopes shared between different life-cycle stages on the response to the schistosomulum.
    Dunne DW; Grabowska AM; Fulford AJ; Butterworth AE; Sturrock RF; Koech D; Ouma JH
    Eur J Immunol; 1988 Jan; 18(1):123-31. PubMed ID: 2450028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. I. Role in the anti-S. mansoni antibody response.
    Velge-Roussel F; Auriault C; Mazingue C; Capron A
    J Immunol; 1991 Dec; 147(11):3960-6. PubMed ID: 1719095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial resemblance in humoral immune response to defined and crude Schistosoma mansoni antigens in an endemic area in Brazil.
    Bethony J; Silveira AM; Alves-Oliveira LF; Thakur A; Gazzinelli G; Correa-Oliveira R; LoVerde PT
    J Infect Dis; 1999 Nov; 180(5):1665-73. PubMed ID: 10515830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.
    Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
    Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies.
    Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A
    Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area.
    Rihet P; Demeure CE; Dessein AJ; Bourgois A
    Eur J Immunol; 1992 Aug; 22(8):2063-70. PubMed ID: 1639104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of an adenovirus expressing EBV-derived vIL-10 in mice infected with Schistosoma mansoni or Leishmania amazonensis: controversial effects on the development of pathological parameters.
    Verwaerde C; Thiam K; Delanoye A; Fernandez-Gomez R; D'Halluin J; Auriault C
    Eur Cytokine Netw; 1999 Jun; 10(2):161-70. PubMed ID: 10400822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human antibody responses against schistosomal antigens. I. Antibodies from patients with Ancylostoma, Ascaris lumbricoides or Schistosoma mansoni infections react with schistosome antigens.
    Correa-Oliveira R; Dusse LM; Viana IR; Colley DG; Santos Carvalho O; Gazzinelli G
    Am J Trop Med Hyg; 1988 Mar; 38(2):348-55. PubMed ID: 3128128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE antibody and resistance to infection. II. Effect of IgE suppression on the early and late skin reaction and resistance of rats to Schistosoma mansoni infection.
    Kigoni EP; Elsas PP; Lenzi HL; Dessein AJ
    Eur J Immunol; 1986 Jun; 16(6):589-95. PubMed ID: 3087755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody reactivity against potato apyrase, a protein that shares epitopes with Schistosoma mansoni ATP diphosphohydrolase isoforms, in acute and chronically infected mice, after chemotherapy and reinfection.
    Faria-Pinto Pd; Montesano MA; Jacinto AA; Santos RS; Bordin FH; Ferreira AP; Penido ML; Coelho PM; Vasconcelos EG
    Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):374-9. PubMed ID: 20721478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
    James SL; Pearce EJ; Sher A
    J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.